Type
Chemical Pharmaceuticals
API for Prostate cancer
PID:
2128395
Model No:
0
Made in:
Taiwan
Quantity:
1000 Piece(s)Available
-
+
Payment:
TT, L/C
Send Inquiry
Supplier Details
ProChem Pharmtech Co., Ltd.
Member Since
2010
Address
No.3, Nanke 1st Rd., Xinshi Dist., Tainan City 741, Taiwan (R.O.C.)
+886-6-5050178
Contact Seller
View company information >
Product Specifications
Key Features
API for Prostate cancer is an antiandrogen medication for prostate cancer marketed by AstraZeneca PLC as Casodex with 29 US-DMF and 10 JP-MF.
Prochem can provide pilot sample of API for Prostate cancer as white to off-white powder with above 99.90% purity, and the process validation will be implemented with above 100 KG/batch in 2019.
Product Name: API for Prostate cancer
CAS Number: 90357-06-5
Indication: Prostate cancer.
Specification: current USP 42
Certificate: Attending PIC/S GMP certificate from TFDA.
Non-infringement Description:
- US4636505 is original patent of API for Prostate cancer, and already expired on 2004.01.13.
- Family patents in Japan are JPH0432061B2 and JPS5933250A, and both expired on 2009.05.28.
- No related patent submitted in Taiwan.
- In this situation, no infringement concerns arise.
Attachment
